[1] JANUARY C T，WANN L S，ALPERT J S，et al.

2014 AHA/ACC/HRS guideline for the management

of patients with atrial fibrillation：a report of the

American College of Cardiology/American Heart

Association Task Force on Practice Guidelines and

the Heart Rhythm Society[J/OL]. J Am Coll Cardiol，

2014，64（21）：e1-e76. http：//sci-hub.tw/10.1016/

j.jacc.2014.03.022.

[2] 代广，夏建华. 原发性肾病综合征合并脑梗死患者的

临床特征及发病机制研究[J]. 中国实用神经疾病杂

志，2017，20（3）：87-89.

[3] JAUCH E C，SAVER J L，ADAMS H P，et al.

Guidelines for the early management of patients with

acute ischemic stroke：a guideline for healthcare

professionals from the American Heart Association/

American Stroke Association[J]. Stroke，2013，44 （3）：870-947.

[4] Cerebral Embolism Study Group. Immediate

anticoagulation of embolic stroke：brain hemorrhage

and management options[J]. Stroke，1984，15（5）：

779-789.

[5] Cerebral Embolism Study Group. Cardioembolic

stroke，early anticoagulation，and brain

hemorrhage[J]. Arch Intern Med，1987，147（4）：

636-640.

[6] BERGE E，ABDELNOOR M，NAKSTAD P H，et

al. Low molecular-weight heparin versus aspirin

in patients with acute ischaemic stroke and atrial

fibrillation：a double-blind randomised study.

HAEST Study Group. Heparin in Acute Embolic

Stroke Trial[J]. Lancet，2000，355（9211）：1205-

1210.

[7] TSIVGOULIS G，SAFOURIS A，ALEXANDROV

A V. Safety of intravenous thrombolysis for acute

ischemic stroke in specific conditions[J]. Expert

Opin Drug Saf，2015，14（6）：845-864.

[8] DEMAERSCHALK B M，KLEINDORFER D

O，ADEOYE O M，et al. Scientific rationale for

the inclusion and exclusion criteria for intravenous

alteplase in acute ischemic stroke：a statement for

healthcare professionals from the American Heart

Association/American Stroke Association[J]. Stroke，

2016，47（2）：581-641.

[9] ANDERSON C S，ROBINSON T，LINDLEY R I，

et al. Low-dose versus standard-dose intravenous

alteplase in acute ischemic stroke[J]. N Engl J Med，

2016，374（24）：2313-2323.